PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16685392-10	2006	The associations of TS/PCNA and DPD/PCNA with the IRs of CDDP, CBDCA remained significant in the 3R/3R group and H-type group.	cddp	57-61	dihydropyrimidine dehydrogenase	Homo sapiens	32-35	
16685392-11	2006	These results suggest that in vitro sensitivity to platinum-derived drugs, CDDP and CBDCA, is associated with PCNA-normalized mRNA expression of TS and DPD in human lung cancer tissues, as affected by the TS polymorphism.	cddp	75-79	dihydropyrimidine dehydrogenase	Homo sapiens	152-155	
12552994-2	2002	DPD activity in peripheral blood mononuclear cells of 30 esophageal cancer patients treated with 5-FU and low-dose CDDP with irradiation was determined at the beginning of each cytostatic cycle, the objective being to determine if DPD activity is related to the occurrence of side-effects and responses to therapy.	cddp	115-119	dihydropyrimidine dehydrogenase	Homo sapiens	0-3	
16685392-8	2006	The inhibition rates (IRs) of CDDP and CBDCA were significantly correlated with TS/PCNA, the ratio of TS/actin and PCNA/actin, and DPD/PCNA, the ratio of DPD/actin and PCNA/actin.	cddp	30-34	dihydropyrimidine dehydrogenase	Homo sapiens	131-134	
16685392-8	2006	The inhibition rates (IRs) of CDDP and CBDCA were significantly correlated with TS/PCNA, the ratio of TS/actin and PCNA/actin, and DPD/PCNA, the ratio of DPD/actin and PCNA/actin.	cddp	30-34	dihydropyrimidine dehydrogenase	Homo sapiens	154-157	
1304835-4	1992	DPD activity was measured in 57 head and neck cancer patients receiving CDDP (100 mg/m2, day 1) plus 5-FU (1 g/m2/day x 5, day 2-day 6).	cddp	72-76	dihydropyrimidine dehydrogenase	Homo sapiens	0-3